Physician profile
Yaphet Tilahun
NPI 1134469166
$29,635.36
in general payments reported to CMS, 2019-2025
12 companies · $4,346 in 2025
The $4,346 reported for 2025 was more than what 87% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $424 · 2021: $125 · 2022: $1,918 · 2023: $6,643 · 2024: $16K · 2025: $4,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Travel and Lodging: $3,638 · Food and Beverage: $2,733 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Travel and Lodging | $3,637.84 |
| Food and Beverage | $2,732.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,924.52 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $832.56 | 2019-2023 | Airseal |
| Thd America, INC. | $224.09 | 2020-2022 | |
| Axonics, INC. | $142.58 | 2023 | Axonics |
| E.R. Squibb & Sons, L.L.C. | $124.86 | 2022 | |
| Stryker Corporation | $110.05 | 2019 | |
| Tela Bio, INC. | $100.00 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $100.00 | 2023 | Skyrizi |
| Coloplast Corp | $26.72 | 2025 | |
| Janssen Biotech, INC. | $18.11 | 2024 | Stelara |
| Ethicon US, LLC | $17.32 | 2020 | |
| Medtronic, INC. | $14.55 | 2023 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaphet Tilahun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.